To amend the Employee Retirement Income Security Act of 1974 to ensure plan fiduciaries have access to de-identified information relating to health claims, and for other purposes.
Summary
HR9228 is an early-stage bill referred to the House Committee on Education and Workforce on June 9, 2026. It proposes to amend ERISA to allow plan fiduciaries access to de-identified health claims data. No financial authorizations are specified, no companion bill exists, and the sponsor is a rank-and-file member. There is no actionable market signal at this stage.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9228 is in extremely early legislative stages — no hearings, no companion bill, no funding authorized.
- 2.The bill would amend ERISA to potentially expand fiduciary access to de-identified claims data, but no specific companies or revenue streams are affected yet.
- 3.No market-moving catalyst exists. Retail investors should avoid trading on this bill until substantive committee action occurs.
Market Implications
The bill is at a procedural stage that provides no actionable market data. Major health insurers and PBMs — UnitedHealth Group ($UNH), Cigna ($CI), Humana ($HUM), CVS Health ($CVS) — will not see measurable revenue or cost changes from this bill in its current form. Healthcare data analytics companies like Truveta (private) or Health Catalyst ($HCAT) could be structurally affected if fiduciary data access accelerates claims data aggregation, but that requires the bill to advance through multiple legislative stages over months or years. No stock should be traded based on this bill introduction.
Full Analysis
HR9228 was introduced on June 9, 2026, by Rep. Robert Onder (R-MO-3) and referred to the House Committee on Education and Workforce. The bill's title indicates an amendment to ERISA granting plan fiduciaries access to de-identified health claims data. At this procedural stage — single referral, no hearings, no markup, no companion in the Senate — the bill is at the very beginning of the legislative path. Because ERISA is a federal statute governing private employer-sponsored health plans, any change to fiduciary data access could have long-term structural effects on healthcare data markets, pharmacy benefit managers (PBMs), and health insurers. However, this bill carries no authorized spending, no direct contract obligations, and no mandated changes to corporate behavior. The sponsor is a junior Republican from Missouri; the committee chair is not the sponsor, reducing near-term passage probability. Without a Senate companion bill or a hearing, this bill is unlikely to advance in the current session. For retail investors, there is no actionable signal — no specific revenue or competitive impact for any public company is determinable from this action alone. The healthcare data analytics and PBM sectors should be monitored if the bill gains committee traction, but today it remains a procedural filing.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →